Photodynamic therapy as salvage therapy for residual microscopic cancer after ultra-low anterior resection: A case report.

BACKGROUND: The rate of positive resection margins (R1) in patients with low rectal cancer is substantial. Recommended remedies such as extended resection or chemoradiotherapy have their own serious drawbacks. It has been reported that photodynamic therapy (PDT) as a remedial treatment for esophageal cancer. Colorectal cancer and esophageal cancer has many similarities, however, PDT as a salvage therapy for rectal cancer is rare. CASE SUMMARY: Here, we describe a 56-year-old man who was admitted to the hospital due to a 6-mo history of hemafecia, which had been aggravated for 1 mo. Colonoscopy revealed a 3 cm × 4 cm ulcerated mass in the rectum 4 cm from the anus. Preoperative pathological examination showed villous adenoma, moderate-to-high-grade dysplasia, good differentiation, and invasion of the mucosal muscle. The patient had R1 after ultra-low anterior resection, but he refused extended resection and experienced severe liver function impairment after 3 cycles of chemotherapy. Ultimately, the patient underwent PDT to remove R1. After five years of follow-up, there was no liver function impairment, recurrence, metastasis, sexual dysfunction, or abnormal defecation function. CONCLUSION: This is the first case worldwide in which R1 of rectal cancer were successfully treated by PDT.

The Influence of Carbon Nitride Nanosheets Doping on the Crystalline Formation of MIL-88B(Fe) and the Photocatalytic Activities.

In this research, bulk graphitic carbon nitride (g-C3 N4 ) is exfoliated and transferred to the carbon nitride nanosheets (CNNSs), which are then coupled with MIL-88B(Fe) to form the hybrid. From the results of the powder X-ray diffraction, scanning electronic microscopy and thermogravimetric analysis, it is found that the doping of CNNSs on the surface of MIL-88(Fe) could maintain the basic structure of MIL-88B(Fe), and the smaller dimension of CNNSs might influence the crystallization process of metal-organic frameworks (MOFs) compared to bulk g-C3 N4 . Besides, the effects of the CNNSs incorporation on photocatalysis are also investigated. Through the photoluminescence spectra, electrochemical measurements, and photocatalytic experiments, the hybrid containing 6% CNNSs is certified to possess the highest catalytic activity to degrade methylene blue and reduce Cr(VI) under visible light. The improvement of the photocatalytic performance can be attributed to the matched energy level which favors the formation of the heterojunctions. Besides, it promotes the charge migration such that the contact between MOFs and CNNSs is more intimate, which can be inferred from the electronic microscopy images. Finally, a possible photocatalytic mechanism is put forward by the relative calculation and the employment of the scavengers to trap the active species.

Efficient photocatalytic degradation of ibuprofen in aqueous solution using novel visible-light responsive graphene quantum dot/AgVO3 nanoribbons.

Single crystalline, non-toxicity, and long-term stability graphene quantum dots (GQDs) were modified onto the AgVO3 nanoribbons by a facile hydrothermal and sintering technique which constructs a unique heterojunction photocatalyst. Characterization results indicate that GQDs are well dispersed on the surface of AgVO3 nanoribbons and GQD/AgVO3 heterojunctions are formed, which can greatly promote the separation efficiency of photogenerated electron-hole pairs under visible light irradiation. By taking advantage of this feature, the GQD/AgVO3 heterojunctions exhibit considerable improvement on the photocatalytic activities for the degradation of ibuprofen (IBP) under visible light irradiation as compared to pure AgVO3. The photocatalytic activity of GQD/AgVO3 heterojunctions is relevant with GQD ratio and the optimal activity is obtained at 3wt% with the highest separation efficiency of photogenerated electron-hole pairs. Integrating the physicochemical and photocatalytic properties, the factors controlling the photocatalytic activity of GQD/AgVO3 heterojunctions are discussed in detail. Moreover, potential photocatalytic degradation mechanisms of IBP via GQD/AgVO3 heterojunctions under visible light are proposed.

Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells.

MicroRNAs (miRs) function as key regulators of gene expression and their deregulation is associated with the carcinogenesis of various cancers. In the present study, the aim was to validate the potential roles and regulatory mechanisms of miR-708 and miR-31 in colorectal cancer (CRC) cells. miR-708 and miR-31 were found to be highly expressed in five CRC tissue samples. Functional studies showed that the inhibition of miR-708 and miR-31 inhibited cell proliferation and invasion, however, promoted apoptosis in vitro. Subsequently, it was identified that miR-708 and miR-31 directly target cyclin-dependent kinase inhibitor 2B (CDKN2B) by binding to the 3' untranslated region, which suppresses the CDKN2B protein levels. In addition, the CDKN2B protein levels were significantly reduced when there was high miR-708 and miR-31 expression in the CRC tissue samples. The results indicate that miR-31 and miR-708 function in an oncogenic manner in CRC development, and inhibition of the two miRs may be used as a therapeutic strategy for patients with CRC.

Meta-analysis of the aldehyde dehydrogenases-2 (ALDH2) Glu487Lys polymorphism and colorectal cancer risk.

A number of studies have explored the association of the aldehyde dehydrogenases-2 (ALDH2) Glu487Lys polymorphism and risk of colorectal cancer; however, the results are inconsistent. We performed this meta-analysis to clarify this issue using all the available evidence. Relevant studies were retrieved by searching PubMed. Eleven case-control studies were included in the meta-analysis, representing 2909 cases and 4903 controls. The pooled results based on all included studies showed a decreased colorectal cancer risk in the analysis of the GA genotype vs. the GG genotype (OR = 0.81, 95%CI = 0.68-0.98, p = 0.03) and in the dominant genetic model analysis (OR = 0.81, 95%CI = 0.67-0.98, p = 0.03). However, there was no statistical difference in the AA vs. GG analysis (OR = 0.74, 95%CI = 0.52-1.06,p = 0.11) and the recessive genetic model analysis (OR = 0.86, 95%CI = 0.69-1.07, p = 0.17). Cumulative meta-analysis based on publication time confirmed these findings. Patients with colorectal cancer had a higher frequency of the GG genotype (OR = 1.10, 95% CI = 1.02-1.20, p = 0.02) and a lower frequency of the GA genotype (OR = 0.89, 95%CI = 0.81-0.98, p = 0.02) comparing with control population. Our results suggested that the ALDH2 Glu487Lys polymorphism may be associated with a decreased risk of colorectal cancer.

An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk.

To investigate the association between p53 codon 72 polymorphisms and gastric cancer risk, a meta-analysis published in 2007 was updated with new data. Relevant literature was retrieved by searching PubMed and statistical analysis conducted using Review Manager software. Twenty-eight case-control studies were included in this meta-analysis, with 6,859 cases and 9,277 controls. The pooled results for all included studies showed that patients with gastric cancer had a borderline lower frequency of the Arg/Arg phenotype (odds ratio (OR) = 0.91, 95 % CI = 0.83-1.00, p = 0.04). When stratified for race, the difference in Arg/Arg frequency was significant among Asians (OR = 0.87, 95 % CI = 0.78-0.97, p = 0.01). On stratifying the various studies we found that, among Asians: (i) patients with cardial gastric cancer had a significantly higher frequency of the Pro/Pro genotype (OR = 1.35, 95 % CI = 1.03-1.77, p = 0.04) than those with non-cardial gastric cancer; (ii) patients with advanced (stage III/IV) gastric cancer had a significantly higher frequency of Arg/Arg (OR = 1.30, 95 % CI = 1.06-1.61, p = 0.01) than those with early (stage I/II) cancer; and (iii) patients with metastasis had a significantly higher frequency of Pro/Pro (OR = 3.31, 95 % CI = 1.31-8.41) than those without metastasis. Our study suggests that, among Asians, the p53 codon 72 Arg/Arg genotype is associated with a modestly decreased risk of gastric cancer, and that this difference in genotype distribution may be associated with cancer stage, location, differentiation and metastasis.